Aravive Stock Total Asset
| ARAVDelisted Stock | USD 1.49 0.21 12.35% |
Aravive fundamentals help investors to digest information that contributes to Aravive's financial success or failures. It also enables traders to predict the movement of Aravive Stock. The fundamental analysis module provides a way to measure Aravive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aravive stock.
Aravive |
Aravive Company Total Asset Analysis
Aravive's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Aravive Total Asset | 62.15 M |
Most of Aravive's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aravive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Aravive has a Total Asset of 62.15 M. This is 99.17% lower than that of the Biotechnology sector and 96.85% lower than that of the Health Care industry. The total asset for all United States stocks is 99.79% higher than that of the company.
Aravive Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aravive's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aravive could also be used in its relative valuation, which is a method of valuing Aravive by comparing valuation metrics of similar companies.Aravive is currently under evaluation in total asset category among its peers.
Aravive Fundamentals
| Return On Equity | -4.76 | |||
| Return On Asset | -1.34 | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | (3.16 M) | |||
| Shares Outstanding | 73.56 M | |||
| Shares Owned By Insiders | 38.68 % | |||
| Shares Owned By Institutions | 8.20 % | |||
| Number Of Shares Shorted | 1.33 M | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 1.73 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 6.99 M | |||
| Gross Profit | (57.8 M) | |||
| EBITDA | (58.4 M) | |||
| Net Income | (39.85 M) | |||
| Cash And Equivalents | 46.83 M | |||
| Cash Per Share | 1.53 X | |||
| Total Debt | 6.27 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.39 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (59.45 M) | |||
| Short Ratio | 0.91 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 0.25 | |||
| Number Of Employees | 23 | |||
| Beta | 2.19 | |||
| Market Capitalization | 2.95 M | |||
| Total Asset | 62.15 M | |||
| Retained Earnings | (616.13 M) | |||
| Working Capital | 35.86 M | |||
| Current Asset | 60.74 M | |||
| Current Liabilities | 11.48 M | |||
| Z Score | -15.89 | |||
| Net Asset | 62.15 M |
About Aravive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aravive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aravive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aravive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |